Microscope Slide Business Cards

16 04 2012

This is too awesome not to pass along. And I plan on making my own as soon as I figure out how to…


Microscope Slide Business Cards.  Genius.

The idea was brought to life as a “viral” (ahem) marketing campaign by a French group, Enfants Terribles. The real name of the person is identifiable only under a microscope.

While these are obviously impractical to a degree, the coolness factor almost outweighs it for me.  If I got one of these at a conference, I’d definitely remember the booth better (take note vendors!).

Slightly relevant side note, I love creative business card designs.  Check out some more (non-pathology related) here.


Enough is Enough, Academic Journals!

27 01 2012


Slashdot Reports:

“The academic publisher Elsevier has attracted controversy for its high prices, the practice of bundling journals for sale to libraries and its support for legislation such as SOPA and the Research Works Act. Fields medal-winning mathematician Tim Gowers decided to go public with a blog post describing how he’ll no longer have anything to do with Elsevier journals, and suggesting that a public website where mathematicians and scientists could register their support for an Elsevier boycott would further the cause. Such a website now exists, with hundreds of academics signing-up so far. John Baez has a nice write-up of the problem and possible solutions.”

I’m not sure how much traction this will really have, but it may bring to light the fact that the academic journal business model is severely overdue for a revamp.  Frankly, it is absurd to charge $30-50 for a 3 page article, which, if you are not working in a large academic center, you have little access to otherwise.   Let alone the fact that the articles were submitted to them basically for free.

It is frustrating to watch history repeat itself constantly, and it is hard to not conclude that media corporations are fueled solely by greed.  We all want to make money; I get it.  I can also see how it might be easier to cling to an outdated business model rather than to innovate to keep pace with technology and the evolving needs of the customer.  Unfortunately, that is no excuse.

I am desperately hoping that what happened with Apple and music (and most recently, textbooks) and Amazon and leisure books will happen with academic journals.  In my opinion, revamping their business models has saved their respective industries.  My fear, however, is that academic journals will remain greedy and obstinate like newspapers and the movie studios who clearly just don’t get it.

While Gowers’ heart is in the right place, gaining real momentum may prove daunting.  Perhaps the only real way to light a fire under the collective rears of the publishers would be to get the support of major academic institutions, but this also may prove daunting for reasons any physician could readily guess.

Call me weird, but I think that potentially life-saving information should be open-sourced, otherwise one could go as far as to conclude that the academic journal co’s are putting prices on the heads of patients (I of course wouldn’t go that far, but one could I suppose…).  Also, I’d venture a guess that most doctors would innately choose to share information over holding it hostage for cash (aka I’d like to think that we are more Woznian than Jobsian).

I know I am not the only physician that thinks this way- a notable exception to this disturbing trend is The Journal of Pathology Informatics.  I don’t need to go on about what a quality journal this is, as anyone that reads this blog is surely familiar with it, but it is worth mentioning, that they get it right-  perhaps the best angle of attack should be to take back our articles and start distributing them ourselves. You don’t need a third party to peer review, publish and distribute your findings anymore.  Articles can be emailed for proofing and peer review and then published online for free.  Like YouTube did for musicians, you don’t need the backing of a mega-corporation to get the word out anymore.

Once we professionals as a whole realize this and become comfortable with the concept, the game is over, and if the publishers don’t get on-board and start updating their practices, they will be left in the dust.  My advice to them is to offer pdf articles for $1.99/article in a single, curated “store” because it is certainly more than the $0.00 they will get when we stop submitting articles to them.

Link to the Elsevier boycott page: http://thecostofknowledge.com/




“The reports of my death are greatly exaggerated” -Mark Twain

1 04 2011

It has been quite awhile since my last update, and for that, I do apologize.  There has been quite a bit going on in my life, both personally and professionally, since my last post, and, as a result 1xO has been simmering on the back burner.

The primary reason for such neglect has been a conscious decision to hunker down and begin the death march towards the AP/CP Boards (for which we finally have a date: May25/26) and 40 hour study weeks on top of 40 hour work weeks do not lend themselves to moonlighting as Chatty Cathys on the interwebs…

Come June, however, I do promise to be back, and with a vengeance at that.  There’s a lot of pent-up prose in this mind of mine that needs to be let out at some point!

So, if you still subscribe to 1xO, thank you very much for your patience; if you’ve left, well, then you won’t read this anyway… 😉

Until then, I leave you with a YouTube Video demonstrating how I would like to be signing out in the next 5 years, thank you in advance industry… 🙂  The video is actually hilarious, imho.  With the serious and silent pristine white-coated gentleman intently/creepily manipulate a slide of obviously normal cerebellum all at the same time demonstrating the power of multi-touch on a huge monolithic Rads-like light box.  Could you imagine singing out 150 cases propped up like that?? haha!

Journal of Pathology Informatics Blog is Live

2 11 2010

Apologies for my recent delinquency, I’ve been settling into board-studying-mode.

This announcement was too important to pass up, however:

The Journal of Pathology Informatics (http://www.jpathinformatics.org/) has just gone live with their blog (http://blog.jpathinformatics.org/), now giving you multiple ways to access their content. In addition, you can find JPI articles in PubMed now as well.

A+ Job!

Roche Acquires BioImagene

24 08 2010

Wow.  Just wow.

Thanks to Digital Pathology Blog for the news.  This could be a pretty big shake-up in the industry.  The deal gives Roche’s subsidiary Ventana a 100% share in BioImagene moving forward.  I, personally, have been a fan of the tech coming out of both camps over the years, and I am super-interested to see where this goes…  Too bad that I didn’t hear about this ahead of time so I could have moved some stocks around 😉

Re-Post of Press Release from DPB:

Roche acquires BioImagene, a leading provider of digital pathology laboratory solutions

Acquisition further strengthens Roche’s global leadership in tissue-based cancer diagnostics and research

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has signed an agreement under which Ventana Medical Systems Inc., a member of the Roche Group, will acquire 100 percent of BioImagene, Inc., a privately held company based in Sunnyvale, California. The purchase price is approximately 100 million US dollars on a debt-free basis. The transaction is subject to customary closing conditions and is expected to close in the coming weeks.

BioImagene is an innovative leader in the field of digital pathology workflow and analysis. Digital pathology is a suite of dynamic, image-based technologies that enable image capture, information management, image analysis and virtual sharing of patients’ tissue samples on glass slides.

“As part of the personalised healthcare approach, pathologists are increasingly involved in generating information with high impact on treatment decisions,” said Daniel O’Day, COO Roche Diagnostics. “The increasing complexity of new tests and technologies creates tremendous need for more sophisticated tools for tissue analysis and diagnosis. BioImagene products will complement and strengthen our current offering in image analysis and information management.”

“With its leadership position in pathology and its global reach, Ventana is the ideal partner for BioImagene,” commented Ajit Singh, CEO of BioImagene, Inc. “Ventana is already a leader in image analysis for breast cancer applications and has a wide range of market-leading diagnostics products used in hospitals and laboratories worldwide. In turn, BioImagene brings to Ventana additional capabilities for scanning and analysing tissue that are not possible in the glass-slide world.”

BioImagene’s products create high-resolution, whole-slide digital images from glass microscope slides. They also provide the software to view, analyze and manage tissue images using a computer, taking pathology beyond traditional microscope applications. In addition, their products improve workflow efficiency in image archiving and retrieval, remote case review, and turnaround time.

“Through this acquisition, Ventana is uniquely positioned to improve laboratory efficiency and help pathologists improve patient care,” said Hany Massarany, President of Ventana Medical Systems, Inc. “Our VIAS Image Analysis System was the first entry into the digital pathology market and is now the leading system for automated image analysis in breast cancer. With BioImagene’s current and future products we will be able to deliver an end-to-end solution from automated staining to comprehensive patient reports.”

Pathology Informatics 2010 Annual Meeting Expanded to Meet Demand

17 08 2010

This is great!!

Bruce Friedman reports over at LabSoft News that this year’s Pathology Informatics Conference will be bigger than ever, smashing the previous record of abstract and e-poster submissions to 60 and 24, respectively!  This is great news, as it seems that Informatics really is a burgeoning field, and people are really starting to take notice of its importance and usefulness in daily practice.

The conference starts September 19, 2010 in Boston and runs for most of the week.  You can get more information about it here.

I really want to go, but am still hoping to get the CAP travel stipend that I applied for……. *cough cough* 😉

http://www.1xObjective.com Now Live!!!

10 08 2010

I finally took the time to go about registering an official domain!  Only took a year and a half, lol.  I’m just glad the domain was still available!

For the record, however, https://robstak.wordpress.com still works as well.

That is all.  Have a great day!

%d bloggers like this: